Zogenix Inc. | Mutual Funds
Mutual Funds that own Zogenix Inc.
Federated Kaufmann Fund
930,000
2.22%
-305,300
0.66%
06/29/2018
T Rowe Price Health Sciences Fund
870,240
2.08%
126,240
0.33%
06/30/2018
iShares Russell 2000 ETF
867,686
2.06%
-462
0.09%
09/06/2018
Vanguard Total Stock Market Index Fund
846,628
2.02%
0
0.01%
07/31/2018
Eagle Small Cap Growth Fund
693,531
1.66%
0
0.57%
06/29/2018
Fidelity Select Biotechnology Portfolio
598,202
1.43%
-19,900
0.31%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
495,210
1.18%
-38,000
1.03%
06/30/2018
iShares Nasdaq Biotechnology ETF
483,350
1.15%
-6,321
0.24%
09/06/2018
Eventide Healthcare & Life Sciences Fund
478,000
1.13%
213,000
3.33%
06/29/2018
Vanguard Extended Market Index Fund
465,361
1.11%
10,600
0.03%
07/31/2018
| Address |
5959 Horton Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.zogenix.com |
| Updated |
07/08/2019 |
| Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. |
